Transfusional iron overload and chelation therapy with deferoxamine and deferiprone (L1)

This publication has 46 references indexed in Scilit:

• Salivary Measurement of Deferiprone Concentrations and Correlation with Serum Levels
  Therapeutic Drug Monitoring, 1997
• Evaluation of a new method of administration of the iron chelating agent deferoxamine
  The Journal of Pediatrics, 1997
• Comparative efficacy and toxicity of desferrioxamine, deferiprone and other iron and aluminium chelating drugs
  Toxicology Letters, 1995
• Selection of a new generation of orally active α‐ketohydroxypyridine iron chelators intended for use in the treatment of iron overload
  American Journal of Hematology, 1993
• Design, Properties, and Effective Use of the Oral Chelator L1 and Other
  Annals of the New York Academy of Sciences, 1990
• L1 (1,2‐dimethyl‐3‐hydroxypyrid‐4‐one) for oral iron chelation in patients with beta‐thalassaemia major
  British Journal of Haematology, 1990
• The effect of synthetic iron chelators on bacterial growth in human serum
  FEMS Microbiology Letters, 1988
• Orally Active Alpha-Ketohydroxypyridine Iron Chelators: Effects on Iron and Other Metal Mobilisations
  Acta Haematologica, 1987
• The study of iron mobilisation from transferrin using α-ketohydroxy heteroaromatic chelators
  Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1986
• Continuous Subcutaneous Administration of Deferoxamine in Patients with Iron Overload
  New England Journal of Medicine, 1977